Plasmodium falciparum dhps and dhfr markers of resistance to sulfadoxine–pyrimethamine five years (2016–2020) after the implementation of seasonal malaria chemoprevention in Cameroon [version 1; peer review: 2 approved, 1 approved with reservations]

Background Antimalarial drug resistance is a major challenge in the fight against malaria. Cameroon implemented seasonal malaria chemoprevention (SMC) with sulfadoxine–pyrimethamine and amodiaquine (SPAQ) to over 1.5 million children aged 3–59 months from 2016, raising concerns whether drug pressure...

詳細記述

書誌詳細

出版年:	Wellcome Open Research
主要な著者:	Palmer M. Netongo, Akindeh M. Nji, Peter Thelma N. Niba, Innocent M. Ali, Randolph Ngwafor, Calvino F. Tah, Germaine Ekoyol, William D. Nana, Jude D. Bigoga, Dorothy F. Ashu, Wilfried F. Mbacham, Christopher B. Tume, Pacome V. K. Tchuenkam, Jean Paul K. Chedjou, Lesley N. Ngum
フォーマット:	論文
言語:	英語
出版事項:	Wellcome 2024-06-01
主題:	sulfadoxine–pyrimethamine drug resistance plasmodium falciparum chemoprevention Pfdhps Cameroon eng
オンライン･アクセス:	https://wellcomeopenresearch.org/articles/9-323/v1